CN104230974B - 一种吡咯并吡啶类化合物及其制备方法 - Google Patents
一种吡咯并吡啶类化合物及其制备方法 Download PDFInfo
- Publication number
- CN104230974B CN104230974B CN201410377110.XA CN201410377110A CN104230974B CN 104230974 B CN104230974 B CN 104230974B CN 201410377110 A CN201410377110 A CN 201410377110A CN 104230974 B CN104230974 B CN 104230974B
- Authority
- CN
- China
- Prior art keywords
- compound
- preparation
- ethyoxyl
- pyrrole
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- -1 Pyrrole-pyridine compound Chemical class 0.000 title abstract description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940125782 compound 2 Drugs 0.000 claims abstract description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 9
- 229940125904 compound 1 Drugs 0.000 claims abstract description 8
- 229940126214 compound 3 Drugs 0.000 claims abstract description 8
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims abstract description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000019270 ammonium chloride Nutrition 0.000 claims abstract description 4
- JQRYUMGHOUYJFW-UHFFFAOYSA-N pyridine;trihydrobromide Chemical compound [Br-].[Br-].[Br-].C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 JQRYUMGHOUYJFW-UHFFFAOYSA-N 0.000 claims abstract description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 3
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 3
- 238000006356 dehydrogenation reaction Methods 0.000 claims abstract description 3
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 3
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 3
- 235000005074 zinc chloride Nutrition 0.000 claims abstract description 3
- 239000011592 zinc chloride Substances 0.000 claims abstract description 3
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 150000005255 pyrrolopyridines Chemical class 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 7
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 238000006713 insertion reaction Methods 0.000 abstract 1
- 150000004702 methyl esters Chemical class 0.000 abstract 1
- 239000004575 stone Substances 0.000 description 13
- RQGPLDBZHMVWCH-UHFFFAOYSA-N pyrrolo[3,2-b]pyrrole Chemical compound C1=NC2=CC=NC2=C1 RQGPLDBZHMVWCH-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FZTLLUYFWAOGGB-UHFFFAOYSA-N 1,4-dioxane dioxane Chemical compound C1COCCO1.C1COCCO1 FZTLLUYFWAOGGB-UHFFFAOYSA-N 0.000 description 1
- BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- DTROUUBKYWYAII-UHFFFAOYSA-N COC(c1c(CC(N2COCC[Si](C)(C)C)=O)c2ncc1)=O Chemical compound COC(c1c(CC(N2COCC[Si](C)(C)C)=O)c2ncc1)=O DTROUUBKYWYAII-UHFFFAOYSA-N 0.000 description 1
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- FCYRSDMGOLYDHL-UHFFFAOYSA-N chloromethoxyethane Chemical compound CCOCCl FCYRSDMGOLYDHL-UHFFFAOYSA-N 0.000 description 1
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 150000005623 oxindoles Chemical class 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 239000003909 protein kinase inhibitor Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical compound C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410377110.XA CN104230974B (zh) | 2014-07-30 | 2014-07-30 | 一种吡咯并吡啶类化合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410377110.XA CN104230974B (zh) | 2014-07-30 | 2014-07-30 | 一种吡咯并吡啶类化合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104230974A CN104230974A (zh) | 2014-12-24 |
CN104230974B true CN104230974B (zh) | 2017-02-08 |
Family
ID=52219967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410377110.XA Active CN104230974B (zh) | 2014-07-30 | 2014-07-30 | 一种吡咯并吡啶类化合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104230974B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000056710A1 (en) * | 1999-03-04 | 2000-09-28 | Glaxo Group Limited | 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
WO2013036611A1 (en) * | 2011-09-07 | 2013-03-14 | Incyte Corporation | Processes and intermediates for making a jak inhibitor |
-
2014
- 2014-07-30 CN CN201410377110.XA patent/CN104230974B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000056710A1 (en) * | 1999-03-04 | 2000-09-28 | Glaxo Group Limited | 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
WO2013036611A1 (en) * | 2011-09-07 | 2013-03-14 | Incyte Corporation | Processes and intermediates for making a jak inhibitor |
Also Published As
Publication number | Publication date |
---|---|
CN104230974A (zh) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111448189A (zh) | 一种联芳基衍生物、其制备方法和在药学上的应用 | |
CN104496983A (zh) | 一种帕博西尼的制备方法 | |
CN104024228A (zh) | 咪唑二酮类化合物及其用途 | |
JP2006518360A (ja) | イマチニブの製造方法、及び該方法により製造されたイマチニブ | |
CN101967140A (zh) | 氘代克里唑蒂尼及其衍生物、制备方法和应用 | |
CN104910158B (zh) | 具有生物活性的5,6,7,8‑四氢吡啶并[3,4‑d]嘧啶化合物及其制备方法和应用 | |
CN107011321A (zh) | 一种人工合成消旋体尼古丁的制备方法 | |
CN105085484B (zh) | 一种富马酸沃诺拉赞的制备方法 | |
CN106810560B (zh) | 一种8-氮杂香豆素的合成方法及其在抗肿瘤药物中的应用 | |
CN104151391A (zh) | 一种具有抗肿瘤作用的齐墩果酸衍生物及其制备方法和用途 | |
CN104761482B (zh) | 3‑(2,2‑二甲基)丙氰基‑3‑烷(芳)基吲哚酮及其制备方法 | |
CN104230974B (zh) | 一种吡咯并吡啶类化合物及其制备方法 | |
CN104892580B (zh) | 一种新型苯并咪唑‑嘧啶胺衍生物、及其应用 | |
CN110922415A (zh) | 一种新型抗肿瘤活性化合物的合成与应用 | |
CN103992319B (zh) | 一种吡啶羧酸类化合物的制备方法 | |
CN108358923B (zh) | 槐定碱吡咯、吲哚类衍生物及其制备方法与应用 | |
CN104774197B (zh) | 一种苯并咪唑衍生物的制备方法 | |
CN104311473B (zh) | 一种哌啶类化合物及其制备方法 | |
CN107739381A (zh) | 莪术醇衍生物及其在制备抗肿瘤药物中的应用 | |
CN104370939B (zh) | 一种手性二氢吡咯类化合物的制备方法 | |
CN105801588B (zh) | 一种那可汀衍生物及其制备方法和应用 | |
CN109824578B (zh) | 一种联-1,4-二氢吡啶类化合物制备方法 | |
CN103896889B (zh) | 拉帕替尼中间体及其制备方法和应用 | |
CN106883185B (zh) | 一种4-氯-2-三氟甲基嘧啶的制备方法 | |
CN101663303A (zh) | 杂芳族化合物、其制备方法以及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: The 300000 Tianjin economic and Technological Development Zone Haiyun Street No. 80 plant No. 17 A6-8 Applicant after: SPHINX SCIENTIFIC LABORATORY (TIANJIN) CO.,LTD. Address before: 300000 Tianjin Binhai New Area Haiyun Street No. 80 No. 17 building A6-8 Applicant before: SPHINX SCIENTIFIC LABORATORY Corp. |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Pyrrole-pyridine compound and preparation method thereof Effective date of registration: 20190926 Granted publication date: 20170208 Pledgee: Tianjin Binhai rural commercial bank Limited by Share Ltd. Pledgor: SPHINX SCIENTIFIC LABORATORY (TIANJIN) CO.,LTD. Registration number: Y2019120000007 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200910 Granted publication date: 20170208 Pledgee: Tianjin Binhai rural commercial bank Limited by Share Ltd. Pledgor: SPHINX SCIENTIFIC LABORATORY (TIANJIN) Co.,Ltd. Registration number: Y2019120000007 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a pyrrolopyridine compound and a preparation method thereof Effective date of registration: 20210526 Granted publication date: 20170208 Pledgee: Tianjin Binhai rural commercial bank Limited by Share Ltd. Pledgor: SPHINX SCIENTIFIC LABORATORY (TIANJIN) Co.,Ltd. Registration number: Y2021120000020 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220519 Granted publication date: 20170208 Pledgee: Tianjin Binhai rural commercial bank Limited by Share Ltd. Pledgor: SPHINX SCIENTIFIC LABORATORY (TIANJIN) CO.,LTD. Registration number: Y2021120000020 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A pyrrolopyridine compound and its preparation method Effective date of registration: 20220525 Granted publication date: 20170208 Pledgee: Tianjin Binhai rural commercial bank Limited by Share Ltd. Pledgor: SPHINX SCIENTIFIC LABORATORY (TIANJIN) CO.,LTD. Registration number: Y2022120000023 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230612 Granted publication date: 20170208 Pledgee: Tianjin Binhai rural commercial bank Limited by Share Ltd. Pledgor: SPHINX SCIENTIFIC LABORATORY (TIANJIN) CO.,LTD. Registration number: Y2022120000023 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A pyrrole pyridine compound and its preparation method Effective date of registration: 20230703 Granted publication date: 20170208 Pledgee: Tianjin Binhai rural commercial bank Limited by Share Ltd. Pledgor: SPHINX SCIENTIFIC LABORATORY (TIANJIN) CO.,LTD. Registration number: Y2023120000052 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |